The ASM submitted comments to the Centers for Disease Control and Prevention on the possession, use, and transfer of select agents and toxins. The comments addressed adding certain Influenza virus strains to the List of Select Agents and Toxins.
The ASM submitted comments to the National Institutes of Health (NIH) RFI on the Framework for the NIH-wide Strategic Plan. The comments will help NIH develop a 5-year strategic plan to outline a vision for biomedical research that will pursue fundamental knowledge about the nature and behavior of living systems and apply that knowledge to extend healthy life and reduce illness and disability.
The ASM presented recommendations to the Centers for Medicare & Medicaid Services at its annual public meeting on payment levels for new tests to be included in the 2016 Clinical Laboratory Fee Schedule.
August 17, 2015 - ASM Comments on Department of State and Commerce Control Regulations for Certain Pathogens
The ASM submitted comments to the US Department of Commerce and the US State Department regarding the Category XIV materials (Toxicological Agents, Including Chemical Agents, Biological Agents, and Associated Equipment) included on the United States Munitions List and the Commerce Control List.
The ASM sent comments on the 21st Centurey Cures Initiative to the House Committee on Energy and Commerce.
- April 21, 2015 - Energy & Environment Provisions in the America COMPETES Reauthorization Act of 2016
- April 7, 2015 - ASM Comments on Impact of Select Agent Regulations
- April 7, 2015 - ASM Comments on Select Agent Regulations Biennial Review
- March 25, 2015 - ASM Letter Concerning CDC Biosafety Recommendations